Volume 5, Issue 2 (12-2023)
pbp 2023, 5(2): 68-85 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gholami A, Karami E, Ebrahimpoorghalehjoghi S, Hajjarzadeh M, Javadi K, Bakhtiari M, et al . The therapeutic effects of Ganoderma lucidum on cancer and immune system such as Anti-Tumor, Anti-Metastatic, Antioxidant, Anti-Angiogenic, Anti-Inflammatory and Immuno-Modulating. pbp 2023; 5 (2) :68-85
URL: http://pbp.medilam.ac.ir/article-1-201-en.html
URL: http://pbp.medilam.ac.ir/article-1-201-en.html
Ali Gholami1 
, Esmail Karami2 , Sahar Ebrahimpoorghalehjoghi3 , Mehrab Hajjarzadeh4 , Kasra Javadi5 , Mehran Bakhtiari6 , Mohamad Mahjoor7 , Fatemeh Rad8 , Mahtab Mehboodi9 , Zahra Mottaghiyan * 10, Reza Akhavan-Sigari11
, Esmail Karami2 , Sahar Ebrahimpoorghalehjoghi3 , Mehrab Hajjarzadeh4 , Kasra Javadi5 , Mehran Bakhtiari6 , Mohamad Mahjoor7 , Fatemeh Rad8 , Mahtab Mehboodi9 , Zahra Mottaghiyan * 10, Reza Akhavan-Sigari11
1- School of Medicine, Arak University of Medical Sciences, Arak, Iran
2- Department of Physiology and Sports Pathology, Faculty of Sport Sciences, Arak University, Arak, Iran
3- Cellular and Molecular Biology Islamic, Azad University, Gorgan Branch, Gorgan, Iran
4- Department of Clinical Biochemistry, School of pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, Iran
5- Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran
6- MSc Student of Parasitology, Students Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
7- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
8- Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
9- Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran
10- Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran , zmottaghiyan@ymail.com
11- 11 Department of Neurosurgery, University Medical Center Tuebingen, Germany 12 Department of Health Care Management and Clinical Research, Collegium Humanum Warsaw Management University Warsaw, Poland
2- Department of Physiology and Sports Pathology, Faculty of Sport Sciences, Arak University, Arak, Iran
3- Cellular and Molecular Biology Islamic, Azad University, Gorgan Branch, Gorgan, Iran
4- Department of Clinical Biochemistry, School of pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, Iran
5- Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran
6- MSc Student of Parasitology, Students Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
7- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
8- Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
9- Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran
10- Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran , zmottaghiyan@ymail.com
11- 11 Department of Neurosurgery, University Medical Center Tuebingen, Germany 12 Department of Health Care Management and Clinical Research, Collegium Humanum Warsaw Management University Warsaw, Poland
Abstract: (658 Views)
Ganoderma lucidum is a fungus pertaining to the Ganodermataceae family, also known as Lingzhi in China and Reishi in Japan. The G. lucidum has been utilized to treat several illnesses, ameliorate health and longevity and it also affects the quality of life. Researches have demonstrated advantageous impacts of G. lucidum as an adjuvant treatment for cancer patients without toxicity. G. lucidum comprises different compounds, which predominantly contain, polysaccharides, triterpenoids, steroids, nucleotides, peptides, fatty acids, which augment the immune system and have effects such as anti-tumor, anti-metastatic, antioxidant, anti-angiogenic, anti-inflammatory. G. lucidum polysaccharides is the essential ingredient in the water dissolved extractives of this mushroom. Polysaccharides and triterpenoids are important because of their anti-cancer properties. Many research has been done on the therapeutic effects and identification of the chemical constituents of this valuable medicinal fungus in the world. In this article, we peruse the consequences of the researchers on the therapeutic effects of this fungus on cancer and introduce compounds reported from it. G. lucidum contains compounds, that play a significant role in the prophylaxis and treatment of cancer, activate our immune system for many defense functions. Researchers' indicate that G. lucidum has a high capacity for acceptance as healthy dietary complement for patient cancer therapy. The reason for some lack of preparation of Ganoderma as a drug may be due to problems with production. Further studies are needed to further illuminate the mechanisms of the modulatory impacts of the immune system also the direct anticancer impacts.
Received: 2023/10/28 | Accepted: 2023/12/1 | Published: 2023/12/1
References
1. Lindequist U, Niedermeyer TH, Jülich W-D. The pharmacological potential of mushrooms. Evidence-Based Complementary and Alternative Medicine. 2005;2(3):285-99.
2. Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied microbiology and biotechnology. 2011;89(5):1323-32.
3. Wu G-S, Lu J-J, Guo J-J, Li Y-B, Tan W, Dang Y-Y, et al. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012;83(2):408-14.
4. Radwan FF, Perez JM, Haque A. Apoptotic and immune restoration effects of ganoderic acids define a new prospective for complementary treatment of cancer. Journal of clinical & cellular immunology. 2011:004.
5. Bishop KS, Kao CH, Xu Y, Glucina MP, Paterson RRM, Ferguson LR. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry. 2015;114:56-65.
6. De Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action. Fungal Diversity. 2012;55(1):1-35.
7. Huang S-Z, Ma Q-Y, Kong F-D, Guo Z-K, Cai C-H, Hu L-L, et al. Lanostane-type triterpenoids from the fruiting body of Ganoderma calidophilum. Phytochemistry. 2017;143:104-10.
8. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IF. Ganoderma lucidum (Lingzhi or Reishi). Herbal Medicine: Biomolecular and Clinical Aspects 2nd edition: CRC Press/Taylor & Francis; 2011.
9. Huang K, Williams W. Antibacterial, antiviral, and antifungal herbs. The pharmacology of Chinese herbs. 1999;3:385-6.
10. Babu PD, Subhasree R. The sacred mushroom “Reishi”-a review. American-Eurasian Journal of Botany. 2008;1(3):107-10.
11. McMEEKIN D. The perception of Ganoderma lucidum in Chinese and Western culture. Mycologist. 2004;18(4):165-9.
12. Wasser SP. Reishi or ling zhi (Ganoderma lucidum). Encyclopedia of dietary supplements. 2005;1:603-22.
13. Chang S-T, Buswell JA. Ganoderma lucidum (Curt.: Fr.) P. karst.(Aphyllophoromycetideae)− a mushrooming medicinal mushroom. International Journal of Medicinal Mushrooms. 1999;1(2).
14. Hsu H-Y, Hua K-F, Lin C-C, Lin C-H, Hsu J, Wong C-H. Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. The Journal of Immunology. 2004;173(10):5989-99.
15. Lin Z-B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. Journal of Pharmacological Sciences. 2005;99(2):144-53.
16. Sanodiya BS, Thakur GS, Baghel RK, Prasad G, Bisen P. Ganoderma lucidum: a potent pharmacological macrofungus. Current pharmaceutical biotechnology. 2009;10(8):717-42.
17. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. In: nd, Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton (FL): CRC Press/Taylor & Llc.; 2011.Francis
18. Upton R. Reishi mushroom Ganoderma lucidum. Standards of analysis, quality control and therapeutics American Herbal Pharmacopoeia and Therapeutic Compendium. 2006.
19. Chan WK, Cheung CCH, Law HKW, Lau YL, Chan GCF. Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. Journal of hematology & oncology. 2008;1(1):9.
20. Ho Y, Yeung J, Chiu P, Tang W, Lin Z, Man R, et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Molecular and cellular biochemistry. 2007;301(1-2):173-9.
21. Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2001;15(3):245-9.
22. Ma H-T, Hsieh J-F, Chen S-T. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 2015;114:109-13.
23. Saltarelli R, Ceccaroli P, Iotti M, Zambonelli A, Buffalini M, Casadei L, et al. Biochemical characterisation and antioxidant activity of mycelium of Ganoderma lucidum from Central Italy. Food Chemistry. 2009;116(1):143-51.
24. Yuen J, Gohel M. The dual roles of Ganoderma antioxidants on urothelial cell DNA under carcinogenic attack. Journal of ethnopharmacology. 2008;118(2):324-30.
25. Kladar NV, Gavaric NS, Božin BN. Ganoderma: insights into anticancer effects. European Journal of Cancer Prevention. 2016;25(5):462-71.
26. Chen X, Hu Z-P, Yang X-X, Huang M, Gao Y, Tang W, et al. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. International immunopharmacology. 2006;6(3):499-508.
27. Zhou Y, Bo S, Deng F, Tao T, Huang H. Effect and mechanism of compound Ganoderma lucidum oral liquid on learning-memory ability in sleep deprived rats. Journal of Zunyi Medical University. 2016.
28. Chang S. Ganoderma–the leader in production and technol-ogy of mushroom neutraceuticals. Recent advances in Ganoderma lucidum research. 1995:43-52.
29. Keizer GJ. The complete encyclopedia of mushrooms: more than 700 pictures and descriptions of mushrooms: Rebo; 1998.
30. Gao J-J, Min B-S, Ahn E-M, Nakamura N, Lee H-K, Hattori M. New triterpene aldehydes, lucialdehydes A—C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chemical and Pharmaceutical Bulletin. 2002;50(6):837-40.
31. Smith J, Rowan N, Sullivan R. Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments: Cancer Research UK London; 2002.
32. McKenna DJ, Jones K, Hughes K, Tyler VM. Botanical medicines: the desk reference for major herbal supplements: Routledge; 2012.
33. Kim HW, Kim BK. Biomedicinal triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst.(Aphyllophoromycetideae). International journal of medicinal mushrooms. 1999;1(2).
34. Baby S, Johnson AJ, Govindan B. Secondary metabolites from Ganoderma. Phytochemistry. 2015;114:66-101.
35. Nie S, Zhang H, Li W, Xie M. Current development of polysaccharides from Ganoderma: isolation, structure and bioactivities. Bioactive Carbohydrates and Dietary Fibre. 2013;1(1):10-20.
36. Badalyan S, Gharibyan N, Kocharyan A. ERSPECTIVE IN USAGE OF BIOACTIVE SUBSTANCES OF MEDICINAL MUSHROOMS IN PHARMACEUTICAL AND COSMETIC INDUSTY. 2007.
37. Chen H-S, Tsai Y-F, Lin S, Lin C-C, Khoo K-H, Lin C-H, et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorganic & medicinal chemistry. 2004;12(21):5595-601.
38. Wu G-S, Guo J-J, Bao J-L, Li X-W, Chen X-P, Lu J-J, et al. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum–a review. Expert opinion on investigational drugs. 2013;22(8):981-92.
39. Sánchez-Martínez JG, Rábago-Castro JL, Vázquez-Sauceda MdlL, Pérez-Castañeda R, Blanco-Martínez Z, Benavides-González F. Effect of β-glucan dietary levels on immune response and hematology of channel catfish Ictalurus punctatus juveniles. Latin american journal of aquatic research. 2017;45(4):690-8.
40. Gao Y, Gao H, Chan E, Tang W, Xu A, Yang H, et al. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunological investigations. 2005;34(2):171-98.
41. Lin Z-b, Zhang H-n. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacologica Sinica. 2004;25:1387-95.
42. Weng C-J, Yen G-C. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clinical & experimental metastasis. 2010;27(5):361-9.
43. Chen AW, Miles PG. Biomedial research and the application of mushroom nutriceuticals from Ganoderma lucidum. 1996.
44. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Reviews International. 1995;11(1):151-66.
45. Miyazaki T, NISHIJIMA M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chemical and Pharmaceutical Bulletin. 1981;29(12):3611-6.
46. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integrative cancer therapies. 2003;2(4):358-64.
47. Gao Y, Wenbo T, Gao H, Lan T, Zhou S. Chemopreventive and tumoricidal properties of Ling Zhi mushroom G. Lucidum: Preclinical and clinical studies. International Journal of Medicinal Mushrooms. 2004;4:95-106.
48. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998;49(6):1651-7.
49. Su C-Y, Shiao M-S, Wang C-T. Potentiation of ganodermic acid S on prostaglandin E1-induced cyclic AMP elevation in human platelets. Thrombosis research. 2000;99(2):135-45.
50. Fang Q-H, Tang Y-J, Zhong J-J. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochemistry. 2002;37(12):1375-9.
51. Lieu C-W, Lee S, Wang S. The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Research. 1992;12(4):1211-5.
52. Lei L, Lin Z. Effect of Ganoderma polysaccharides on T cell subpopulations and production of interleukin 2 in mixed lymphocyte response. Yao xue xue bao= Acta pharmaceutica Sinica. 1992;27(5):331-5.
53. Zhang Q-H, Lin Z-B. The antitumor activity of Ganoderma lucidum (Curt.: Fr.) P. Karst.(Ling Zhi)(Aphyllophoromycetideae) polysaccharides is related to tumor necrosis factor-α and interferon-γ. International journal of medicinal mushrooms. 1999;1(3).
54. Ooi LS, Ooi VEC, Fung MC. Induction of gene expression of immunomodulatory cytokines in the mouse by a polysaccharide from Ganoderma lucidum (Curt.: Fr.) P. Karst.(Aphyllophoromycetideae). International Journal of Medicinal Mushrooms. 2002;4(1).
55. Liao S-F, Liang C-H, Ho M-Y, Hsu T-L, Tsai T-I, Hsieh YS-Y, et al. Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes. Proceedings of the National Academy of Sciences. 2013;110(34):13809-14.
56. Lin S-B, Li C-H, Lee S-S, Kan L-S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life sciences. 2003;72(21):2381-90.
57. Sedighimehr N, Manshadi FD. Electrical Stimulation for Lower Urinary Tract Dysfunction in People with Multiple Sclerosis: A Systematic Review. Journal of Clinical Physiotherapy Research. 2018;3(2):48-53.
58. Chen N-H, Liu J-W, Zhong J-J. Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. Journal of pharmacological sciences. 2008;108(2):212-6.
59. Li Y-B, Wang R, Wu H-L, Li Y-H, Zhong L-J, Yu H-M, et al. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells. Oncology reports. 2008;20(3):549-56.
60. Ko KK, Murthee KG, Koh T, Tan T. Reishi (lingzhi) ingestion mistaken for persistent Clonorchis infection. Pathology-Journal of the RCPA. 2014;46(6):576-8.
61. Tomasi S, Lohezic-Le Devehat F, Sauleau P, Bezivin C, Boustie J. Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2004;59(4):290-3.
62. Müller CI, Kumagai T, O’Kelly J, Seeram NP, Heber D, Koeffler HP. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia research. 2006;30(7):841-8.
63. Shang D, Zhang J, Wen L, Li Y, Cui Q. Preparation, characterization, and antiproliferative activities of the Se-containing polysaccharide SeGLP-2B-1 from Se-enriched Ganoderma lucidum. Journal of agricultural and food chemistry. 2009;57(17):7737-42.
64. Hong Kj, Dunn DM, Shen CL, Pence BC. Effects of ganoderma lucidum on apoptotic and anti‐inflammatory function in HT‐29 human colonic carcinoma cells. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2004;18(9):768-70.
65. Liu J, Shiono J, Shimizu K, Kukita A, Kukita T, Kondo R. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorganic & medicinal chemistry letters. 2009;19(8):2154-7.
66. Johnson BM, Doonan BP, Radwan FF, Haque A. Ganoderic acid DM: an alternative agent for the treatment of advanced prostate cancer. The open prostate cancer journal. 2010;3:78.
67. Hsu C-L, Yu Y-S, Yen G-C. Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. Journal of agricultural and food chemistry. 2008;56(11):3973-80.
68. Gao JJ, Hirakawa A, Min BS, Nakamura N, Hattori M. In vivo antitumor effects of bitter principles from the antlered form of fruiting bodies of Ganoderma lucidum. Journal of natural medicines. 2006;60(1):42-8.
69. Jiang J, Jedinak A, Sliva D. Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. Biochemical and biophysical research communications. 2011;415(2):325-9.
70. Wu Q-P, Xie Y-Z, Li S-Z, La Pierre DP, Deng Z, Chen Q, et al. Tumour cell adhesion and integrin expression affected by Ganoderma lucidum. Enzyme and microbial technology. 2006;40(1):32-41.
71. Lu Q-Y, Jin Y-S, Zhang Q, Zhang Z, Heber D, Go VLW, et al. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer letters. 2004;216(1):9-20.
72. Lin C-H, Sheu G-T, Lin Y-W, Yeh C-S, Huang Y-H, Lai Y-C, et al. A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochemistry. 2010;45(9):1537-42.
73. Li W, Nie S, Chen Y, Wang Y, Li C, Xie M. Enhancement of cyclophosphamide-induced antitumor effect by a novel polysaccharide from Ganoderma atrum in sarcoma 180-bearing mice. Journal of agricultural and food chemistry. 2011;59(8):3707-16.
74. Ouyang M-z, Lin L-z, Lv W-j, Zuo Q, Lv Z, Guan J-s, et al. Effects of the polysaccharides extracted from Ganoderma lucidum on chemotherapy-related fatigue in mice. International journal of biological macromolecules. 2016;91:905-10.
75. Calviño E, Manjón JL, Sancho P, Tejedor MC, Herráez A, Diez JC. Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk. Journal of ethnopharmacology. 2010;128(1):71-8.
76. Li K, Na K, Sang T, Wu K, Wang Y, Wang X. The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo. Oncology reports. 2017;38(5):2803-13.
77. Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Kurashiki K, et al. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum. Food Chemistry. 2007;100(4):1691-6.
78. Lin T-Y, Hsu H-Y. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Cancer letters. 2016;375(2):340-8.
79. Lin TY, Hsu HY, Sun WH, Wu TH, Tsao SM. Induction of Cbl‐dependent epidermal growth factor receptor degradation in Ling Zhi‐8 suppressed lung cancer. International journal of cancer. 2017;140(11):2596-607.
80. Hsin I-L, Ou C-C, Wu M-F, Jan M-S, Hsiao Y-M, Lin C-H, et al. GMI, an immunomodulatory protein from Ganoderma microsporum, potentiates cisplatin-induced apoptosis via autophagy in lung cancer cells. Molecular pharmaceutics. 2015;12(5):1534-43.
81. Na K, Li K, Sang T, Wu K, Wang Y, Wang X. Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo. International journal of oncology. 2017;50(5):1541-54.
82. Wu K, Na K, Chen D, Wang Y, Pan H, Wang X. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. International journal of oncology. 2018;53(6):2356-68.
83. Ajith T, Sudheesh N, Roshny D, Abishek G, Janardhanan K. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. Experimental gerontology. 2009;44(3):219-23.
84. Smina T, De S, Devasagayam T, Adhikari S, Janardhanan K. Ganoderma lucidum total triterpenes prevent radiation-induced DNA damage and apoptosis in splenic lymphocytes in vitro. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2011;726(2):188-94.
85. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidants from Ganoderma lucidum. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 1999;13(6):529-31.
86. Hasnat M, Pervin M, Lim BO. Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of Ganoderma lucidum grown on germinated brown rice. Molecules. 2013;18(6):6663-78.
87. Zhu L, Luo X, Tang Q-jT, Liu Y, Zhou S, Yang Y, et al. Isolation, purification, and immunological activities of a low-molecular-weight polysaccharide from the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (Higher Basidiomycetes). International journal of medicinal mushrooms. 2013;15(4).
88. XiaoPing C, Yan C, ShuiBing L, YouGuo C, JianYun L, LanPing L. Free radical scavenging of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes and immunity activities in cervical carcinoma rats. Carbohydrate Polymers. 2009;77(2):389-93.
89. Kao P-F, Wang S-H, Hung W-T, Liao Y-H, Lin C-M, Yang W-B. Structural characterization and antioxidative activity of low-molecular-weights beta-1, 3-glucan from the residue of extracted Ganoderma lucidum fruiting bodies. BioMed Research International. 2011;2012.
90. Jiang H, Sun P, He J, Shao P. Rapid purification of polysaccharides using novel radial flow ion-exchange by response surface methodology from Ganoderma lucidum. Food and bioproducts processing. 2012;90(1):1-8.
91. Liu W, Wang H, Yao W, Gao X, Yu L. Effects of sulfation on the physicochemical and functional properties of a water-insoluble polysaccharide preparation from Ganoderma lucidum. Journal of agricultural and food chemistry. 2010;58(6):3336-41.
92. Lin Z-B, Wang M-Y, Liu Q, Che Q-M. Effects of total triterpenoids extract from Ganoderma Iucidum (Curt.: Fr.) P. Karst.(Reishi Mushroom) on experimental liver injury models induced by carbon tetrachloride or D-galactosamine in mice. International Journal of Medicinal Mushrooms. 2002;4(4).
93. Zhang C, Li Y, Hu Y, Peng Y, Ahmad Z, Li J-S, et al. Porous Yolk–Shell Particle Engineering via Nonsolvent-Assisted Trineedle Coaxial Electrospraying for Burn-Related Wound Healing. ACS applied materials & interfaces. 2019;11(8):7823-35.
94. Wu H, Tang S, Huang Z, Zhou Q, Zhang P, Chen Z. Hepatoprotective effects and mechanisms of action of triterpenoids from lingzhi or reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes) on α-amanitin-induced liver injury in mice. International journal of medicinal mushrooms. 2016;18(9).
95. Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. Journal of Burn Care & Research. 2010;31(1):158-75.
96. Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, et al. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. Journal of Pharmacy and Pharmacology. 2011;63(5):725-35.
97. Wu X, Guan H, Li J, Guo J, Hou B. Evaluation of antitumour action of Ganoderma lucidum extract in hepatocarcinoma mice. Afr J Pharm Pharmacol. 2012;6:2884-7.
98. Cao Q-Z, Lin Z-b. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacologica Sinica. 2004;25:833-8.
99. Song YS, Kim S-H, Sa J-H, Jin C, Lim C-J, Park E-H. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. Journal of ethnopharmacology. 2004;90(1):17-20.
100. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells. Biochemical and biophysical research communications. 2005;330(1):46-52.
101. Cao Q-z, Lin Z-B. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sciences. 2006;78(13):1457-63.
102. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Molecular cancer research. 2006;4(4):221-33.
103. Dehghan MF, Amiri Y, Sedighi MN, AKBARZADE BA, REZA SA. Ultrasonic Thickness of Abdominal Wall Muscles in Non-Specific Chronic Low Back Pain Patients based on STarT Questionnaire. 2019.
104. Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. The Journal of clinical investigation. 2015;125(9):3347-55.
105. Joseph S, Sabulal B, George V, Antony K, Janardhanan K. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta pharmaceutica. 2011;61(3):335-42.
106. Li EK, Tam LS, Wong CK, Li WC, Lam CW, Wachtel‐Galor S, et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double‐blind, randomized, placebo‐controlled pilot trial. Arthritis Care & Research. 2007;57(7):1143-50.
107. Liu Y-H, Tsai C-F, Kao M-C, Lai Y-L, Tsai J-J. Effectiveness of Dp2 nasal therapy for Dp2-induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION. 2003;36(4):236-42.
108. Nagai K, Ueno Y, Tanaka S, Sagami S, Nishiyama S, Shinagawa K, et al. Tu1851 The Potential Role of Polysaccharides Derived From Ganoderma Lucidum Fungus Mycelia (designated as MAK) on Ameliorating Indomethacin-Induced Small Intestinal Injuries Through GM-CSF. Gastroenterology. 2015;148(4):S-919.
109. Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj NJ, et al. Anticancer and anti-inflammatory properties of Ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients. 2017;9(3):210.
110. Sliva D, Loganathan J, Jiang J, Jedinak A, Lamb JG, Terry C, et al. Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS One. 2012;7(10).
111. Jin H, Jin F, Jin J-X, Xu J, Tao T-T, Liu J, et al. Protective effects of Ganoderma lucidum spore on cadmium hepatotoxicity in mice. Food and chemical toxicology. 2013;52:171-5.
112. Gao Y, Zhou S, Huang M, Lan J, Gao H. Mechanisms for the protective effects of Ganoderma lucidum polysaccharide fraction on indomethacin-induced ulcer in the rat. Life Sci. 2002;72(6):731-45.
113. Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas‐mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. Journal of leukocyte biology. 2002;72(1):207-16.
114. Shieh Y-H, Liu C-F, Huang Y-K, Yang J-Y, Wu I-L, Lin C-H, et al. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. The American journal of Chinese medicine. 2001;29(03n04):501-7.
115. 115. Chang C-J, Chen Y-YM, Lu C-C, Lin C-S, Martel J, Tsai S-H, et al. Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin. Innate immunity. 2014;20(3):301-11.
116. Hahne JC, Meyer SR, Dietl J, Honig A. The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro. International journal of oncology. 2014;45(1):373-82.
117. Lu J, Sun LX, Lin ZB, Duan XS, Ge ZH, Xing EH, et al. Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage. Phytotherapy Research. 2014;28(2):200-6.
118. Wang C-Z, Basila D, Aung HH, Mehendale SR, Chang W-T, McEntee E, et al. Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. The American journal of Chinese medicine. 2005;33(05):807-15.
119. Zhao S, Ye G, Fu G, CHEnG J-X, YAnG BB, PEnG C. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. International journal of oncology. 2011;38(5):1319-27.
120. Kim KC, Jun HJ, Kim JS, Kim IG. Enhancement of radiation response with combined Ganoderma lucidum and Duchesnea chrysantha extracts in human leukemia HL-60 cells. International journal of molecular medicine. 2008;21(4):489-98.
121. Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, et al. The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. International journal of oncology. 2014;44(6):2009-15.
122. Feliz-Mosquea Y, Suarez-Arroyo I, Loperena Y, Cubano LA, Martinez-Montemayor MM. Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells. AACR; 2015.
123. Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, et al. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PloS one. 2013;8(2).
124. Moslemi M, Moradi Y, Dehghanbanadaki H, Afkhami H, Khaledi M, Sedighimehr N, et al. The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis. BMC cancer. 2021;21(1):1-12.
125. Jin X, Beguerie JR, Sze DMy, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews. 2012(6).
126. Gao Y, Dai X, Chen G, Ye J, Zhou S. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly®) in patients with advanced lung cancer. International Journal of Medicinal Mushrooms. 2003;5(4).
127. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of Ganopoly®(A ganoderma lucidum polysaccharide extract) on the immune functions in Advanced‐Stage cancer patients. Immunological investigations. 2003;32(3):201-15.
128. Oka S, Tanaka S, Yoshida S, Hiyama T, Ueno Y, Ito M. Ganoderma lucidum Mycelia Suppresses the Development of Colorectal Adenomas. Hiroshima J Med Sci. 2010;59(1):1-6.
129. Bao P-P, Lu W, Cui Y, Zheng Y, Gu K, Chen Z, et al. Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. PLoS One. 2012;7(6).
130. Chen QM, Alpert JS. Nutraceuticals: evidence of benefit in clinical practice? The American journal of medicine. 2016;129(9):897-8.
131. Xia D. Effects of Ganoderma polysaccharides on immune function in mice. J Beijing Med Univ. 1989;21:533-7.
132. Lei L. Effects of Ganoderma polysaccharides on the activity of DNA polymerase α in spleen cells stimulated by alloantigents in mice in vitro. J Beijing Med Univ. 1991;23:329-33.
133. Zhang Q, Lin Z. Effect of Ganoderma lucidum polysaccharides B on TNFalpha and IFNgamma production and their mRNA expression. Journal of Beijing Medical University. 1999;31(2):179-83.
134. Wang Y-Y, Khoo K-H, Chen S-T, Lin C-C, Wong C-H, Lin C-H. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorganic & medicinal chemistry. 2002;10(4):1057-62.
135. Chen W-C, Hau D-M, Wang C-C, Lin I-H, Lee S-S. Effects of Ganoderma lucidum and Krestin on subset T-cell in spleen of γ-irradiated mice. The American journal of Chinese medicine. 1995;23(03n04):289-98.
136. Li A, Shuai X, Jia Z, Li H, Liang X, Su D, et al. Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. Journal of translational medicine. 2015;13(1):100.
137. Zhang J, Tang Q, Zhou C, Jia W, Da Silva L, Nguyen LD, et al. GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life sciences. 2010;87(19-22):628-37.
138. Wang SY, Hsu ML, Hsu HC, Lee SS, Shiao MS, Ho CK. The anti‐tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International journal of cancer. 1997;70(6):699-705.
139. Kuo M-C, Weng C-Y, Ha C-L, Wu M-J. Ganoderma lucidum mycelia enhance innate immunity by activating NF-κB. Journal of ethnopharmacology. 2006;103(2):217-22.
140. Han M-D, Lee E-S, Kim Y-K, Lee J-W, Jeong H, Yoon K-H. Production of Nitric Oxide in Raw 264.7 Macrophages treated with Ganoderan, the ${beta}-Glucan $ of Ganoderma lucidum. The Korean Journal of Mycology. 1998;26(2):246-55.
141. Oh J-Y, Cho K-J, Chung S-H, Kim J-H, Lillehoj H, Chung K-S. Activation of macrophages by GLB, a protein-polysaccharide of the growing tips of Ganoderma lucidum. Yakhak Hoeji. 1998;42(3):302-6.
142. Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. International immunopharmacology. 2009;9(11):1272-80.
143. Gunawardena D, Bennett L, Shanmugam K, King K, Williams R, Zabaras D, et al. Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages. Food chemistry. 2014;148:92-6.
144. Habijanic J, Berovic M, Boh B, Plankl M, Wraber B. Submerged cultivation of Ganoderma lucidum and the effects of its polysaccharides on the production of human cytokines TNF-α, IL-12, IFN-γ, IL-2, IL-4, IL-10 and IL-17. New biotechnology. 2015;32(1):85-95.
145. Yang HS, Choi YJ, Oh HH, Jo JH, Jung HK, Seo KS, et al. Anti-inflammatory effects of Ganoderma lucidum water extracts fermented using lactic acid bacteria based on HO-1 expression in LPS-stimulated RAW 264.7 macrophages. Food Science and Biotechnology. 2015;24(1):161-7.
146. Cao L, Lin Z. Comparison of the effects of polysaccharides from wood-cultured and bag-cultured Ganoderma lucidum on murine spleen lymphocyte proliferation in vitro. Yao xue xue bao= Acta pharmaceutica Sinica. 2003;38(2):92-7.
147. Bao X-F, Wang X-S, Dong Q, Fang J-N, Li X-Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 2002;59(2):175-81.
148. Zhang J, Tang Q, Zimmerman-Kordmann M, Reutter W, Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life sciences. 2002;71(6):623-38.
149. Cao L-Z, Lin Z-B. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunology letters. 2002;83(3):163-9.
150. Lai C-Y, Hung J-T, Lin H-H, Alice LY, Chen S-H, Tsai Y-C, et al. Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 2010;28(31):4945-54.
151. Cao L-Z, Lin Z-B. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacologica Sinica. 2003;24(4):321-6.
152. Chien CM, Cheng J-L, Chang W-T, Tien M-H, Wu W-Y, Chang Y-H, et al. Cell phenotype analysis using a cell fluid-based microchip with high sensitivity and accurate quantitation. Journal of Chromatography B. 2003;795(1):1-8.
153. Won S. Enhancement of splenic NK cytotoxic activity by extracts of Ganoderma lucidum mycelium in mice. J Biomed Lab Sci. 1989;2:201-13.
154. Lee S-S, Wei Y-H, Chen C-F, Wang S-Y, Chen K-Y. Antitumor effects of Ganoderma lucidum. 1995;6(1):1-12.
155. Zhang S, Pang G, Chen C, Qin J, Yu H, Liu Y, et al. Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response. Carbohydrate polymers. 2019;205:192-202.
156. Salai EP, Maduravoyal C. Salutary effect of ferulic acid against D-galactosamine challenged liver damage. Journal of Biological Sciences. 2008;8(8):1271-9.
157. Babu PR, Bhuvaneswar C, Sandeep G, Ramaiah CV, Rajendra W. Hepatoprotective role of Ricinus communis leaf extract against d-galactosamine induced acute hepatitis in albino rats. Biomedicine & Pharmacotherapy. 2017;88:658-66.
158. Han K-H, Hashimoto N, Hashimoto M, Noda T, Shimada K-i, Lee C-H, et al. Red potato extract protects from D-galactosamine-induced liver injury in rats. Bioscience, biotechnology, and biochemistry. 2006:0608040047-.
159. Sreepriya M, Devaki T, Balakrishna K, Apparanantham T. Effect of Indigofera tinctoria Linn on liver antioxidant defense system during D-galactosamine I endotoxin-induced acute hepatitis in rodents. 2001.
160. Liu Z, Ma X, Deng B, Huang Y, Bo R, Gao Z, et al. Development of liposomal Ganoderma lucidum polysaccharide: Formulation optimization and evaluation of its immunological activity. Carbohydrate polymers. 2015;117:510-7.
161. Liu Z, Xing J, Zheng S, Bo R, Luo L, Huang Y, et al. Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydrate polymers. 2016;142:141-8.
162. Yao Z-C, Jin L-J, Ahmad Z, Huang J, Chang M-W, Li J-S. Ganoderma lucidum polysaccharide loaded sodium alginate micro-particles prepared via electrospraying in controlled deposition environments. International journal of pharmaceutics. 2017;524(1-2):148-58.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |